Live from the NIH registry
Studies recruiting near Indianapolis right now
Top 25 of 958 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Indianapolis, Indiana (0.9 mi)
· Sponsor: Medtronic
Clinical Decision Support Tool in PARDS Pilot Study
Ventilation Therapy; Complications, Ventilator-Induced Lung Injury
N/A
Interventional 180 participants sought
Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: Children's Hospital Los Angeles
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Ascension St. Vincent's Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Indiana University, IU Health Methodist Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Indiana University Health Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Syndax Pharmaceuticals
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
Innovative Hematology, Inc. (IHI) — Indianapolis, Indiana (0.9 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Kartos Therapeutics, Inc.
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Large Cell Lymphoma, Diffuse, Relapsed Cancer
Phase 2
Interventional 35 participants sought
Indiana University Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Dipenkumar Modi
Increasing Equity in Lung Cancer Screening
Lung Cancer
N/A
Interventional 144 participants sought
Eskenazi Health — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
Cervical Myelopathy in Hip Fracture Patients
Cervical Myelopathy, Hip Fractures
N/A
Interventional 75 participants sought
Eskenazi Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
IU Health University Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Indiana University Health Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Josephson Wallack Munshower Neurology, P.C. — Indianapolis, Indiana (0.9 mi)
· Sponsor: Annovis Bio Inc.
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
Indiana University School of Medicine - Methodist Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Investigative Clinical Research of Indiana - Indianapolis /ID# 260468 — Indianapolis, Indiana (0.9 mi)
· Sponsor: AbbVie
Options for Pain Management Using Nonpharmacological Strategies
Pain
N/A
Interventional 296 participants sought
Richard L. Roudebush VA Medical Center, Indianapolis, IN — Indianapolis, Indiana (0.9 mi)
· Sponsor: VA Office of Research and Development
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: NRG Oncology
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Vulvar Diseases, HPV Infection
Phase 2
Interventional 27 participants sought
Ascension St. Vincent — Indianapolis, Indiana (0.9 mi)
· Sponsor: Frantz Viral Therapeutics, LLC
Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction
Free Flap Reconstruction
Phase 4
Interventional 128 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
HER2 Vaccine for Locally Advanced Breast Cancer
Breast Cancer, HER2-positive Breast Cancer
Phase 1
Interventional 36 participants sought
Indiana University Melvin & Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Pravin T.P Kaumaya
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Franciscan Health ( Site 0077) — Indianapolis, Indiana (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 Mutation, Low-grade Glioma
Phase 2
Interventional 96 participants sought
Riley Hospital for Children at Indiana University Health — Indianapolis, Indiana (0.9 mi)
· Sponsor: University of California, San Francisco
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Eli Lilly and Company
Assessing Pain and Effectiveness of Carevix Device for IUD Insertions
IUD, Abnormal Uterine Bleeding
N/A
Interventional 100 participants sought
Indiana University Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
Study of Resmetirom in Children and Adolescents With MASH
MASH, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 2
Interventional 61 participants sought
Riley Hospital for Children at IU Health — Indianapolis, Indiana (0.9 mi)
· Sponsor: Madrigal Pharmaceuticals, Inc.